Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $112.503 0.58% Open 111.5 Day High 113.6 52 Week High 133.6 52 Week ...

Industrial Automation Food Processing and Agriculture Chemical and Petrochemical Wastewater Treatment Telecommunications The CE marking process involved rigorous testing to ensure compliance with ...

Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...

Regulatory approval for FemBloc is still pending completion of the CE mark process and final EMA review, leaving uncertainties regarding its market launch in Europe. The press release includes a ...

(PRNewsfoto/Zimmer Biomet Holdings, Inc.) "Following the success of RibFix Advantage Fixation System in the United States and other markets, we are excited to introduce it in CE Mark markets and ...

"CE marking our software as a medical device whilst maintaining the ability to move fast and innovate was a challenging process," said Kirby, who is chief technology officer at Vinehealth.

The CE mark is the first regulatory approval received ... risks related to the uncertain and time-consuming development and regulatory process, including the risk that Cerus may be unable to ...

Zimmer Biomet (ZBH) announced its RibFix Advantage Fixation System has received CE Mark certification – the first CE Mark for an intrathoracic rib fixation system. Discover the latest stocks ...